BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Health Robotics Appoints Steve Thomas to Board of Directors


3/28/2013 8:56:19 AM

BOZEN, Sud-Tirol, Italy, March 28, 2013 /PRNewswire/ --Health Robotics today announced the appointment of Steve Thomas to its Board of Directors, effective immediately. Mr. Thomas spent 15 years in the Computer Industry and four years in Information Services before becoming President of Pyxis Corporation in 1997 and Group President of Cardinal Health in 1999. In 2003 he acquired Valueselling Associates, a global sales training company. Then, in 2007 he became Chairman and CEO of For Health Technologies Inc., which under his leadership pioneered efforts in the Sterile Compounding Automation sector before being acquired by Baxa Corporation and later by Baxter International.

Steve Thomas stated: "I joined the Board of Health Robotics because they have the best products in the health care industry for improving patient safety and removing real costs in the IV room. They already have the top integrated solutions in the Sterile Compounding Automation sector, and now they are poised to build a world-class company, enabling them to broaden their global impact in health care. Based on my research and health care experience, Health Robotics is very well positioned for high growth and continued market leadership for years to come."

Gaspar DeViedma, Health Robotics' Executive Vice President and Board Member, stated: "We are delighted to improve our Board's know-how with Steve Thomas. He has broad global experience in information technology, information services, health care, and sales training. He has a passion for health care innovation and has been very successful in leading high growth companies. Steve is well known to our USA customer base and will help us in taking Health Robotics to the highest possible level in recognition as the undisputed global leader in IV Automation. He has been tasked by the Board to lead the company's re-capitalization efforts and to take Health Robotics to unprecedented levels of success."

About Health Robotics:

Founded in 2006 and now reaching 80% total IV Robots market share in the world [including over 90% the Oncology Robots global market], Health Robotics is the undisputed leading supplier of life-critical intravenous medication robots, providing over 350 hospital installations in 5 continents with the only fully-integrated robotics-based technology, IV Workflow, and manual compounding software automation solutions. Health Robotics' second generation products [i.v.STATION, i.v.SOFT, and i.v.STATION ONCO] have been found [through scientific and peer-reviewed studies[1],[2] to greatly contribute to ease hospitals' growing pressures to improve patient safety[1], increase throughput, and contain costs[1]. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug[1] and diluent[1] exchange errors, improve drug potency[2], decrease other medical mistakes and sterility risks, work more efficiently[1], reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES